117 related articles for article (PubMed ID: 27230039)
41. Adenosine deaminase activity and fibronectin levels in bronchoalveolar lavage fluid in sarcoidosis and tuberculosis.
Albera C; Mabritto I; Ghio P; Solidoro P; Marchetti L; Pozzi E
Sarcoidosis; 1993 Mar; 10(1):18-25. PubMed ID: 7907809
[TBL] [Abstract][Full Text] [Related]
42. Ultrastructural features of alveolitis in sarcoidosis.
Takemura T; Hiraga Y; Oomichi M; Oritsu M; Akiyama O; Matsui Y; Eishi Y; Mikami R
Am J Respir Crit Care Med; 1995 Jul; 152(1):360-6. PubMed ID: 7599846
[TBL] [Abstract][Full Text] [Related]
43. CCL18 in serum, BAL fluid and alveolar macrophage culture supernatant in interstitial lung diseases.
Cai M; Bonella F; He X; Sixt SU; Sarria R; Guzman J; Costabel U
Respir Med; 2013 Sep; 107(9):1444-52. PubMed ID: 23831213
[TBL] [Abstract][Full Text] [Related]
44. T-cell phenotypes in bronchoalveolar lavage fluid, blood and lymph nodes in pulmonary sarcoidosis--indication for an airborne antigen as the triggering factor in sarcoidosis.
Darlington P; Haugom-Olsen H; von Sivers K; Wahlström J; Runold M; Svjatoha V; Porwit A; Eklund A; Grunewald J
J Intern Med; 2012 Nov; 272(5):465-71. PubMed ID: 22469005
[TBL] [Abstract][Full Text] [Related]
45. Density of phenotypic markers on BAL T-lymphocytes in hypersensitivity pneumonitis, pulmonary sarcoidosis and bronchiolitis obliterans with organizing pneumonia.
Satake N; Nagai S; Kawatani A; Kaneshima H; Tanaka S; Takeuchi M; Izumi T
Eur Respir J; 1993 Apr; 6(4):477-82. PubMed ID: 8491296
[TBL] [Abstract][Full Text] [Related]
46. Influence of age on manifestation, VC and TLCO values, and bronchoalveolar lavage cell counts of sarcoidosis and extrinsic allergic alveolitis.
Sterclova M; Paluch P; Skibova J; Vasakova M
Clin Respir J; 2015 Jan; 9(1):39-44. PubMed ID: 24406019
[TBL] [Abstract][Full Text] [Related]
47. Th1/Th2 cytokine pattern in bronchoalveolar lavage fluid and induced sputum in pulmonary sarcoidosis.
Tsiligianni I; Antoniou KM; Kyriakou D; Tzanakis N; Chrysofakis G; Siafakas NM; Bouros D
BMC Pulm Med; 2005 Jun; 5():8. PubMed ID: 15978129
[TBL] [Abstract][Full Text] [Related]
48. Tumor-infiltrating lymphocytes expressing the tissue resident memory marker CD103 are associated with increased survival in high-grade serous ovarian cancer.
Webb JR; Milne K; Watson P; Deleeuw RJ; Nelson BH
Clin Cancer Res; 2014 Jan; 20(2):434-44. PubMed ID: 24190978
[TBL] [Abstract][Full Text] [Related]
49. Increased macrophage inflammatory protein-1alpha and macrophage inflammatory protein-1beta levels in bronchoalveolar lavage fluid of patients affected by different stages of pulmonary sarcoidosis.
Capelli A; Di Stefano A; Lusuardi M; Gnemmi I; Donner CF
Am J Respir Crit Care Med; 2002 Jan; 165(2):236-41. PubMed ID: 11790661
[TBL] [Abstract][Full Text] [Related]
50. CD103 Expression on Regulatory and Follicular T Cells in Lymph Nodes, Bronchoalveolar Lavage Fluid and Peripheral Blood of Sarcoidosis Patients.
d'Alessandro M; Gangi S; Cavallaro D; Bergantini L; Mezzasalma F; Cattelan S; Baglioni S; Abbritti M; Cameli P; Bargagli E
Life (Basel); 2022 May; 12(5):. PubMed ID: 35629428
[TBL] [Abstract][Full Text] [Related]
51. Bronchoalveolar lavage in sarcoidosis.
Drent M; Mansour K; Linssen C
Semin Respir Crit Care Med; 2007 Oct; 28(5):486-95. PubMed ID: 17975776
[TBL] [Abstract][Full Text] [Related]
52. [Changes in the percentage of activated lymphocytes in bronchoalveolar lavage fluid in patients with clinical improvement of sarcoidosis].
Piesiak P; Jankowska R; Passowicz-Muszyńska E
Wiad Lek; 2006; 59(9-10):644-8. PubMed ID: 17338122
[TBL] [Abstract][Full Text] [Related]
53. [Bronchoalveolar lavage and pulmonary sarcoidosis].
Pejcić T; Stanković I; Rancić M; Ristić L
Med Pregl; 2005; 58 Suppl 1():11-5. PubMed ID: 16526259
[TBL] [Abstract][Full Text] [Related]
54. Involvement of central immunity in uncomplicated diverticular disease.
Cianci R; Iacopini F; Petruzziello L; Cammarota G; Pandolfi F; Costamagna G
Scand J Gastroenterol; 2009; 44(1):108-15. PubMed ID: 18759154
[TBL] [Abstract][Full Text] [Related]
55. Induced sputum in patients with interstitial lung disease: a non-invasive surrogate for certain parameters in bronchoalveolar lavage fluid.
Sobiecka M; Kus J; Demkow U; Filewska M; Jozwik A; Radwan-Rohrenschef P; Chorostowska-Wynimko J
J Physiol Pharmacol; 2008 Dec; 59 Suppl 6():645-57. PubMed ID: 19218691
[TBL] [Abstract][Full Text] [Related]
56. Bronchoalveolar lavage in interstitial lung diseases: does the recovery rate affect the results?
Schildge J; Nagel C; Grun C
Respiration; 2007; 74(5):553-7. PubMed ID: 17496412
[TBL] [Abstract][Full Text] [Related]
57. Bronchoalveolar lavage impact in sarcoidosis: study of 40 cases.
Bacha D; Ayadi-Kaddour A; Ismail O; El Mezni F
Tunis Med; 2009 Jan; 87(1):38-42. PubMed ID: 19522425
[TBL] [Abstract][Full Text] [Related]
58. CD4/CD8 lymphocytes in BALF during the efferent phase of lung delayed-type hypersensitivity reaction induced by single antigen inhalation.
Grubek-Jaworska H; Hoser G; Droszcz P; Chazan R
Med Sci Monit; 2001; 7(5):878-83. PubMed ID: 11535927
[TBL] [Abstract][Full Text] [Related]
59. [Analysis of the results of bronchoalveolar lavage (BALF) in patients with pulmonary sarcoidosis].
Dizdarević Z; Zutić H; Masić I; Konjicija A; Dalagija F; Mehić B; Lovre V; Pećanac M
Med Arh; 1993; 47(3-4):87-90. PubMed ID: 7934231
[TBL] [Abstract][Full Text] [Related]
60. [Establishment of a simple fluorescent microscopy method for measurement of the CD4/CD8 ratio in BALF].
Konoike Y; Nishikawa K; Imai T; Katada H; Narita N
Nihon Kyobu Shikkan Gakkai Zasshi; 1990 Mar; 28(3):441-7. PubMed ID: 2120496
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
